Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

Please share Science & Enterprise

Trial Underway Testing Bioelectronic Incontinence Device

neurons

The first participants are enrolled in a clinical trial of an implanted bio-feedback device to help women control urinary incontinence, sudden or stress-related urges to urinate. . . . → Read More: Trial Underway Testing Bioelectronic Incontinence Device

Project to Sequence 20K Dog and Cat Genomes

Dog's nose

Some 20,000 dogs and cats are expected to have their genomes sequenced in the next 10 years for a publicly available database to enable precision medicine for pets. . . . → Read More: Project to Sequence 20K Dog and Cat Genomes

BioNTech to Provide Personal Cancer Immunotherapies in UK

Vials and bottles

The biotechnology company BioNTech SE is partnering with the U.K. government to provide up to 10,000 personalized cancer immunotherapy treatments by 2030. . . . → Read More: BioNTech to Provide Personal Cancer Immunotherapies in UK

New Company Creating High-Capacity Gene Therapies to the Brain

Herpes simplex virus illustration

A new business is underway developing gene therapies with higher capacities than most current technologies to treat neurodegenerative disorders. . . . → Read More: New Company Creating High-Capacity Gene Therapies to the Brain

Mental Health VR Companies Merge, Raise $13M

Subway car interior

Two developers of virtual reality therapy technology for mental health disorders are combining their operations, and raising $13 million in venture funds. . . . → Read More: Mental Health VR Companies Merge, Raise $13M

FDA Clears AI Heart Failure Detection System

Digital heart health graphic

The Food and Drug Administration authorized for marketing an algorithm-driven medical device for diagnosing a common, but difficult to detect, type of heart failure. . . . → Read More: FDA Clears AI Heart Failure Detection System

Sustained-Released Eye Treatment Company Raises $11.9M

Red-blue-green eye

A company creating extended-release delivery techniques for eye therapies is raising $11.9 million in its first venture funding round. . . . → Read More: Sustained-Released Eye Treatment Company Raises $11.9M

Biotech, M.D. Anderson Partner on Precision Drug Design

Network pointer

A company discovering therapies with artificial intelligence is partnering with M.D. Anderson Cancer Center on new small-molecule precision medicines. . . . → Read More: Biotech, M.D. Anderson Partner on Precision Drug Design

Dual-Action Vaccine Shown to Attack, Shrink Solid Tumors

Breast tumor microenvironment

Research with lab animals shows an experimental cancer vaccine generates immune-system cells that infiltrate solid tumors and reduce the tumor’s protective environment. . . . → Read More: Dual-Action Vaccine Shown to Attack, Shrink Solid Tumors

Trial Shows Antibody Neutralizes, Reduces HIV Virus

T-cell infected by HIV

Results from a clinical trial show an experimental one-time antibody therapy, even at low doses, lowers levels of HIV virus in people living with the disease. . . . → Read More: Trial Shows Antibody Neutralizes, Reduces HIV Virus